- Home
- LPSN vs YI Comparison
LPSN vs YI Comparison
Compare LPSN & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- YI
- Stock Information
- Founded
- LPSN 1995
- YI 2010
- Country
- LPSN United States
- YI China
- Employees
- LPSN N/A
- YI N/A
- Industry
- LPSN EDP Services
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- LPSN Technology
- YI Consumer Staples
- Exchange
- LPSN Nasdaq
- YI Nasdaq
- Market Cap
- LPSN 72.8M
- YI 70.0M
- IPO Year
- LPSN 2000
- YI N/A
- Fundamental
- Price
- LPSN $0.78
- YI $8.14
- Analyst Decision
- LPSN Hold
- YI
- Analyst Count
- LPSN 3
- YI 0
- Target Price
- LPSN $1.20
- YI N/A
- AVG Volume (30 Days)
- LPSN 1.1M
- YI 12.9K
- Earning Date
- LPSN 05-07-2025
- YI 06-10-2025
- Dividend Yield
- LPSN N/A
- YI N/A
- EPS Growth
- LPSN N/A
- YI N/A
- EPS
- LPSN N/A
- YI N/A
- Revenue
- LPSN $292,025,000.00
- YI $1,973,017,082.00
- Revenue This Year
- LPSN N/A
- YI N/A
- Revenue Next Year
- LPSN $0.43
- YI N/A
- P/E Ratio
- LPSN N/A
- YI N/A
- Revenue Growth
- LPSN N/A
- YI N/A
- 52 Week Low
- LPSN $0.52
- YI $4.15
- 52 Week High
- LPSN $2.08
- YI $12.90
- Technical
- Relative Strength Index (RSI)
- LPSN 48.59
- YI 53.37
- Support Level
- LPSN $0.65
- YI $6.91
- Resistance Level
- LPSN $0.80
- YI $8.16
- Average True Range (ATR)
- LPSN 0.06
- YI 0.38
- MACD
- LPSN -0.00
- YI 0.04
- Stochastic Oscillator
- LPSN 46.32
- YI 91.79
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.